Lidocaine Hci 3.88%

Prescription

Handelsnamen: Bruselix Gel

Darreichungsform

Topical

Applikationsweg

TOPICAL

Hersteller

PureTek Corporation

About This Medication

DESCRIPTION: Bruselix™ Gel contains 38.8 mg of Lidocaine HCI per gram in a mild acidic vehicle with Aloe Barbadensis (Aloe Vera) Leaf Juice, Aqua (Purified Water), Arnica Montana (Arnica) Flower Extract, Citric Acid, Ethylhexylglycerin, Glycerin, Hydroxyethylcellulose, PEG-4, Phenoxyethanol, Potassium Sorbate, Propylene Glycol, Sodium Benzoate. Lidocaine HCl is chemically designated as acetamide, 2-(diethylamino)-N-(2,6 dimethylphenyl), and has the following structure: Label

Wirkstoffe

Wirkstoff	Stärke
Lidocaine Hydrochloride	-

Indikationen und Anwendung

INDICATIONS: For the temporary relief of pain.

Dosierung und Verabreichung

DOSAGE: Apply a thin film to the affected area two or three times daily or as directed by a licensed healthcare practitioner.

Side Effects Overview

ADVERSE REACTIONS: During or immediately after treatment, the skin at the site of treatment may develop erythema or edema or may be the locus of abnormal sensation.

Warnhinweise und Vorsichtsmaßnahmen

WARNINGS: For external use only. Not for ophthalmic use.

Kontraindikationen

CONTRAINDICATIONS: Tuberculous or fungal lesions of skin vaccinia, varicella and acute herpes simplex and in persons who have shown hypersensitivity to any of its components. Lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

Frequently Asked Questions

INDICATIONS: For the temporary relief of pain.

DOSAGE: Apply a thin film to the affected area two or three times daily or as directed by a licensed healthcare practitioner.

WARNINGS: For external use only. Not for ophthalmic use.

CONTRAINDICATIONS: Tuberculous or fungal lesions of skin vaccinia, varicella and acute herpes simplex and in persons who have shown hypersensitivity to any of its components. Lidocaine is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type.

Lidocaine Hci 3.88% is a prescription medication. You will need a valid prescription from a licensed healthcare provider.

References & Data Sources

• DailyMed — Lidocaine Hci 3.88% drug label (National Library of Medicine)
• openFDA — Lidocaine Hci 3.88% label data (U.S. Food & Drug Administration)
• RxNorm — RXCUI 2675768 (NLM Normalized Drug Names)
• NDC Directory — Lidocaine Hci 3.88% (FDA National Drug Code)

Medizinischer Haftungsausschluss

Die Informationen auf dieser Seite dienen ausschließlich zu Bildungszwecken und sollten nicht als Ersatz für professionellen ärztlichen Rat, Diagnose oder Behandlung verwendet werden.

Wenden Sie sich bei Fragen zu einem medizinischen Zustand oder einem Arzneimittel stets an Ihren Arzt oder einen anderen qualifizierten Angehörigen der Gesundheitsberufe.

Datenquellen: DailyMed (NLM), openFDA, MFDS